Suppr超能文献

肾功能可预测秋水仙碱毒性:痛风患者秋水仙碱预防性使用指南。

Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout.

作者信息

Wallace S L, Singer J Z, Duncan G J, Wigley F M, Kuncl R W

机构信息

Department of Medicine, State University of New York Health Sciences Center, Brooklyn.

出版信息

J Rheumatol. 1991 Feb;18(2):264-9.

PMID:2023222
Abstract

In order to establish the degree of renal malfunction necessary for colchicine toxicity in patients receiving it daily for the prevention of recurrent acute gout, we obtained serum creatinine levels and measured or estimated creatinine clearances in a consecutive series of 17 patients with demonstrated colchicine myotoxicity. An estimate of creatinine clearance, based on ideal body weight and age, was nearly always 50 ml/min or less, and was the most practical predictor of the risk of toxicity. By comparison, patients with gout from the same clinical data base, but without myotoxicity, had normal renal function. The data yield clear guidelines for safe use of colchicine chronically.

摘要

为确定每日服用秋水仙碱预防复发性急性痛风的患者发生秋水仙碱毒性所需的肾功能损害程度,我们获取了17例已证实有秋水仙碱肌毒性患者的血清肌酐水平,并测量或估算了肌酐清除率。基于理想体重和年龄估算的肌酐清除率几乎总是50毫升/分钟或更低,是毒性风险最实用的预测指标。相比之下,来自同一临床数据库但无肌毒性的痛风患者肾功能正常。这些数据为长期安全使用秋水仙碱提供了明确的指导原则。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验